Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV — Stella

Home/Obesity and Overweight/

View on ClinicalTrials.gov

Recruiting

Back to Obesity and Overweight trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

John A Burns School of Medicine, Honolulu, Hawaii

Key details

Phase

Safety & dosing

Sponsor

University of Hawaii

Enrollment target

~12 participants

Started

November 2025

Primary completion

July 2026

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.